Joel S. Schuman, MD, FACS, highlights home tonometry, virtual visual fields, and portable OCT devices as promising tools, ...

Bausch + Lomb has partnered with the glaucoma community once again, launching its fifth annual fundraising challenge and ...

Glaucoma, the silent thief of sight, damages the optic nerve without early symptoms, leading to irreversible vision loss.

Faster thinning of cpRNFL and mGCIPL is associated with visual field progression in glaucoma, with rates of –1.02 and –1.04 ...

In matched cohorts of more than 41,000 patients each, use of tirzepatide was linked to a significantly reduced risk of primary open-angle glaucoma compared with selective GLP-1 receptor agonists (risk ...

Laser eye surgeries can help treat glaucoma by improving the outflow of fluid in the eye. Types of surgeries include trabeculoplasty, iridotomy, and cyclophotocoagulation. Doctors may suggest a ...

As part of the fundraising challenge with GRF, Bausch + Lomb will match every dollar raised during January, up to $20,000. All proceeds will support critical research for glaucoma, a leading cause of ...

Eating leafy green vegetables is “consistently associated with” a lower risk for developing primary open-angle glaucoma, ...

Doctors may recommend eye drops, oral medications, laser treatment, or surgery for glaucoma. These interventions can help reduce eye pressure and protect the optic nerve from further damage. However, ...

Although there already are "smart" contact lenses that monitor the eyes for signs of glaucoma, the devices are typically only worn when the patient is awake. A new type of contact lens, however, ...

Use of calcium channel blockers (CCBs), particularly cardioselective agents, had a modest but statistically significant association with glaucoma, a large meta-analysis showed. Overall, patients with ...